4 KiB
| type | domain | description | confidence | source | created | title | agent | sourced_from | scope | sourcer | related | supports | reweave_edges | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| claim | ai-alignment | The White House AI Action Plan addresses AI-bio convergence risk through output-layer screening while leaving the input-layer institutional review framework ungoverned after DURC/PEPP rescission | likely | CSET Georgetown, Council on Strategic Risks, RAND Corporation (July-August 2025) | 2026-04-27 | AI Action Plan substitutes nucleic acid synthesis screening for DURC/PEPP institutional oversight creating biosecurity governance gap through category substitution | theseus | ai-alignment/2026-04-27-theseus-ai-action-plan-biosecurity-synthesis.md | structural | Theseus (synthesis across CSET, CSR, RAND) |
|
|
|
AI Action Plan substitutes nucleic acid synthesis screening for DURC/PEPP institutional oversight creating biosecurity governance gap through category substitution
Three independent policy research institutions (CSET Georgetown, Council on Strategic Risks, RAND Corporation) converge on the same finding: the White House AI Action Plan (July 2025) implements category substitution in biosecurity governance. The plan explicitly acknowledges that AI can provide 'step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal' but addresses this risk through three instruments operating at the synthesis/output layer: (1) mandatory nucleic acid synthesis screening for federally funded institutions, (2) OSTP-convened data sharing for screening fraudulent customers, and (3) CAISI evaluation of frontier AI for national security risks. RAND confirms these instruments govern 'AI-bio risk at the output/screening layer but leave the input/oversight layer ungoverned.' CSR states the plan 'does not replace DURC/PEPP institutional review framework' which was rescinded separately with a 120-day replacement deadline that was missed (7+ months with no replacement as of April 2026). The category substitution is structural: nucleic acid screening flags whether specific synthesis orders are suspicious, while DURC/PEPP institutional review decides whether research programs should exist at all. These govern different stages of the research pipeline. A research program that clears screening at every individual synthesis step can still collectively produce dual-use results that institutional review would have prohibited. CSET notes that Kratsios/Sacks/Rubio as co-authors signals the plan is 'fundamentally a national security document that appropriates science policy, not a science policy document that addresses security' — the institutional authority for biosecurity governance shifted from HHS/OSTP-as-science to NSA/State-as-security. RAND concludes: 'Institutions are left without clear direction on which experiments require oversight reviews.' The convergence across three independent institutions from different analytical traditions (CSET political, CSR urgency-focused, RAND technical) within 10 days of the AI Action Plan's release provides strong evidence this is not interpretation but structural feature of the policy.